$AUXL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AUXILIUM PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AUXILIUM PHARMACEUTICALS INC. Get notifications about new insider transactions in AUXILIUM PHARMACEUTICALS INC for free.
Page: < prev 1 ... 2 3 4 5 6 7 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 05 2010 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 29.98 | 208 | 6,236 | 7,276 | 7.1 K to 7.3 K (+2.94 %) |
| Oct 02 2009 | AUXL | AUXILIUM PHARMACEU ... | LANGER DENNIS | Director | Grant | A | 34.21 | 292 | 9,989 | 1,033 | 741 to 1 K (+39.41 %) |
| Oct 02 2009 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Grant | A | 34.21 | 18 | 616 | 631 | 613 to 631 (+2.94 %) |
| Oct 02 2009 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 34.21 | 310 | 10,605 | 2,602 | 2.3 K to 2.6 K (+13.53 %) |
| Oct 02 2009 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Grant | A | 34.21 | 438 | 14,984 | 3,800 | 3.4 K to 3.8 K (+13.03 %) |
| Oct 02 2009 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 34.21 | 193 | 6,603 | 7,068 | 6.9 K to 7.1 K (+2.81 %) |
| Sep 29 2009 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Option Exercise | M | 3.75 | 5,000 | 18,750 | 0 | |
| Sep 29 2009 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Option Exercise | M | 3.13 | 2,000 | 6,250 | 0 | |
| Sep 29 2009 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Option Exercise | M | 4.25 | 8,000 | 34,000 | 0 | |
| Sep 29 2009 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Sell | S | 34.83 | 15,000 | 522,449 | 3,000 | 18 K to 3 K (-83.33 %) |
| Sep 29 2009 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Buy | M | 3.75 | 5,000 | 18,750 | 18,000 | 13 K to 18 K (+38.46 %) |
| Sep 29 2009 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Buy | M | 3.13 | 2,000 | 6,250 | 13,000 | 11 K to 13 K (+18.18 %) |
| Sep 29 2009 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Buy | M | 4.25 | 8,000 | 34,000 | 11,000 | 3 K to 11 K (+266.67 %) |
| Sep 29 2009 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Sell | S | 34.83 | 12,600 | 438,857 | 3,000 | 15.6 K to 3 K (-80.77 %) |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 13.16 | 1,000 | 13,160 | 37,363 | |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 9.15 | 1,500 | 13,725 | 40,500 | |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 5.36 | 3,833 | 20,545 | 93,501 | |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Sell | S | 35.43 | 6,333 | 224,390 | 9,382 | 15.7 K to 9.4 K (-40.30 %) |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 13.16 | 1,000 | 13,160 | 15,715 | 14.7 K to 15.7 K (+6.80 %) |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 9.15 | 1,500 | 13,725 | 14,715 | 13.2 K to 14.7 K (+11.35 %) |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 5.36 | 3,833 | 20,545 | 13,215 | 9.4 K to 13.2 K (+40.85 %) |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Option Exercise | M | 13.39 | 12,400 | 166,036 | 70,200 | |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Sell | S | 36.15 | 6,200 | 224,109 | 12,832 | 19 K to 12.8 K (-32.58 %) |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Sell | S | 35.48 | 6,200 | 219,973 | 19,032 | 25.2 K to 19 K (-24.57 %) |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Buy | M | 13.39 | 12,400 | 166,036 | 25,232 | 12.8 K to 25.2 K (+96.63 %) |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Sell | S | 34.00 | 550 | 18,700 | 12,832 | 13.4 K to 12.8 K (-4.11 %) |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | M | 4.78 | 4,000 | 19,120 | 71,067 | |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Sell | S | 30.70 | 4,000 | 122,811 | 17,751 | 21.8 K to 17.8 K (-18.39 %) |
| Sep 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Buy | M | 4.78 | 4,000 | 19,120 | 21,751 | 17.8 K to 21.8 K (+22.53 %) |
| Sep 14 2009 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Gift | G | 0.00 | 58,339 | 0 | 58,339 | 0 to 58.3 K |
| Sep 14 2009 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Gift | G | 0.00 | 58,339 | 0 | 80,000 | 138.3 K to 80 K (-42.17 %) |
| Sep 14 2009 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Gift | G | 0.00 | 30,317 | 0 | 138,339 | 108 K to 138.3 K (+28.07 %) |
| Sep 14 2009 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Gift | G | 0.00 | 30,317 | 0 | 21,607 | 51.9 K to 21.6 K (-58.39 %) |
| Sep 10 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | M | 4.78 | 4,000 | 19,120 | 75,067 | |
| Sep 10 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Sell | S | 30.00 | 4,000 | 120,007 | 17,751 | 21.8 K to 17.8 K (-18.39 %) |
| Sep 10 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Buy | M | 4.78 | 4,000 | 19,120 | 21,751 | 17.8 K to 21.8 K (+22.53 %) |
| Jul 28 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 13.16 | 1,000 | 13,160 | 38,363 | |
| Jul 28 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 9.15 | 1,500 | 13,725 | 42,000 | |
| Jul 28 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 5.36 | 3,833 | 20,545 | 97,334 | |
| Jul 28 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Sell | S | 32.13 | 6,333 | 203,469 | 9,382 | 15.7 K to 9.4 K (-40.30 %) |
| Jul 28 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 13.16 | 1,000 | 13,160 | 15,715 | 14.7 K to 15.7 K (+6.80 %) |
| Jul 28 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 9.15 | 1,500 | 13,725 | 14,715 | 13.2 K to 14.7 K (+11.35 %) |
| Jul 28 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 5.36 | 3,833 | 20,545 | 13,215 | 9.4 K to 13.2 K (+40.85 %) |
| Jul 28 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Sell | S | 32.00 | 550 | 17,600 | 13,382 | 13.9 K to 13.4 K (-3.95 %) |
| Jul 21 2009 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Payment of Exercise | F | 30.00 | 16,032 | 480,960 | 108,022 | 124.1 K to 108 K (-12.92 %) |
| Jul 17 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | M | 4.78 | 4,000 | 19,120 | 79,067 | |
| Jul 17 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Sell | S | 30.01 | 4,000 | 120,025 | 17,751 | 21.8 K to 17.8 K (-18.39 %) |
| Jul 17 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Buy | M | 4.78 | 4,000 | 19,120 | 21,751 | 17.8 K to 21.8 K (+22.53 %) |
| Jul 02 2009 | AUXL | AUXILIUM PHARMACEU ... | LANGER DENNIS | Director | Grant | A | 31.38 | 119 | 3,734 | 741 | 622 to 741 (+19.13 %) |
| Jul 02 2009 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Grant | A | 31.38 | 63 | 1,977 | 613 | 550 to 613 (+11.45 %) |
| Jul 02 2009 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 31.38 | 243 | 7,625 | 2,292 | 2 K to 2.3 K (+11.86 %) |
| Jul 02 2009 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Grant | A | 31.38 | 342 | 10,732 | 3,362 | 3 K to 3.4 K (+11.32 %) |
| Jul 02 2009 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 31.38 | 258 | 8,096 | 6,875 | 6.6 K to 6.9 K (+3.90 %) |
| Jul 02 2009 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 31.38 | 258 | 8,096 | 6,875 | 6.6 K to 6.9 K (+3.90 %) |
| Jun 30 2009 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Option Exercise | M | 7.81 | 30,000 | 234,300 | 440,000 | |
| Jun 30 2009 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Sell | S | 30.30 | 30,000 | 908,898 | 124,054 | 154.1 K to 124.1 K (-19.47 %) |
| Jun 30 2009 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Buy | M | 7.81 | 30,000 | 234,300 | 154,054 | 124.1 K to 154.1 K (+24.18 %) |
| Jun 17 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | M | 4.78 | 4,000 | 19,120 | 83,067 | |
| Jun 17 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Sell | S | 27.21 | 4,000 | 108,839 | 17,751 | 21.8 K to 17.8 K (-18.39 %) |
| Jun 17 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Buy | M | 4.78 | 4,000 | 19,120 | 21,751 | 17.8 K to 21.8 K (+22.53 %) |
| Jun 22 2009 | AUXL | AUXILIUM PHARMACEU ... | CREDIT SUISSE/ | 10% Owner | Sell | S | 20.11 | 116,913 | 2,350,922 | 3,094,541 | 3.2 M to 3.1 M (-3.64 %) |
| Jun 22 2009 | AUXL | AUXILIUM PHARMACEU ... | CREDIT SUISSE/ | 10% Owner | Sell | S | 20.06 | 45,319 | 908,891 | 3,211,454 | 3.3 M to 3.2 M (-1.39 %) |
| Jun 22 2009 | AUXL | AUXILIUM PHARMACEU ... | CREDIT SUISSE/ | 10% Owner | Sell | S | 20.07 | 193,778 | 3,889,241 | 3,256,773 | 3.5 M to 3.3 M (-5.62 %) |
| Jun 22 2009 | AUXL | AUXILIUM PHARMACEU ... | CREDIT SUISSE/ | 10% Owner | Sell | S | 20.07 | 56,596 | 1,136,040 | 3,450,551 | 3.5 M to 3.5 M (-1.61 %) |
| Jun 12 2009 | AUXL | AUXILIUM PHARMACEU ... | MCKEE WILLIAM | Director | Option Exercise | A | 25.99 | 15,000 | 389,850 | 15,000 | |
| Jun 12 2009 | AUXL | AUXILIUM PHARMACEU ... | LANGER DENNIS | Director | Option Exercise | A | 25.99 | 15,000 | 389,850 | 15,000 | |
| Jun 12 2009 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Option Exercise | A | 25.99 | 15,000 | 389,850 | 15,000 | |
| Jun 12 2009 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Option Exercise | A | 25.99 | 15,000 | 389,850 | 15,000 | |
| Jun 12 2009 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Option Exercise | A | 25.99 | 15,000 | 389,850 | 15,000 | |
| Jun 12 2009 | AUXL | AUXILIUM PHARMACEU ... | Bescherer Edwin A Jr | Director | Option Exercise | A | 25.99 | 15,000 | 389,850 | 15,000 | |
| Jun 12 2009 | AUXL | AUXILIUM PHARMACEU ... | ALTOMARI ALFRED | Director | Option Exercise | A | 25.99 | 15,000 | 389,850 | 15,000 | |
| Jun 12 2009 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Option Exercise | A | 25.99 | 50,000 | 1,299,500 | 50,000 | |
| May 27 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | M | 4.78 | 4,000 | 19,120 | 87,067 | |
| May 27 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Sell | S | 25.02 | 4,000 | 100,092 | 17,751 | 21.8 K to 17.8 K (-18.39 %) |
| May 27 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Buy | M | 4.78 | 4,000 | 19,120 | 21,751 | 17.8 K to 21.8 K (+22.53 %) |
| May 20 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Payment of Exercise | F | 23.14 | 3,008 | 69,605 | 17,751 | 20.8 K to 17.8 K (-14.49 %) |
| Apr 20 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | M | 4.78 | 500 | 2,390 | 91,067 | |
| Apr 20 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | M | 4.78 | 3,500 | 16,730 | 91,567 | |
| Apr 20 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Sell | S | 25.00 | 500 | 12,500 | 20,759 | 21.3 K to 20.8 K (-2.35 %) |
| Apr 20 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Buy | M | 4.78 | 500 | 2,390 | 21,259 | 20.8 K to 21.3 K (+2.41 %) |
| Apr 20 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Sell | S | 25.01 | 3,500 | 87,533 | 20,759 | 24.3 K to 20.8 K (-14.43 %) |
| Apr 20 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Buy | M | 4.78 | 3,500 | 16,730 | 24,259 | 20.8 K to 24.3 K (+16.86 %) |
| Apr 02 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Payment of Exercise | F | 27.61 | 903 | 24,932 | 13,932 | 14.8 K to 13.9 K (-6.09 %) |
| Apr 02 2009 | AUXL | AUXILIUM PHARMACEU ... | LANGER DENNIS | Director | Grant | A | 27.72 | 135 | 3,742 | 622 | 487 to 622 (+27.72 %) |
| Apr 02 2009 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Grant | A | 27.72 | 63 | 1,746 | 550 | 487 to 550 (+12.94 %) |
| Apr 02 2009 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 27.72 | 394 | 10,922 | 2,103 | 1.7 K to 2.1 K (+23.05 %) |
| Apr 02 2009 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 27.72 | 328 | 9,092 | 6,631 | 6.3 K to 6.6 K (+5.20 %) |
| Apr 02 2009 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Grant | A | 27.72 | 567 | 15,717 | 3,074 | 2.5 K to 3.1 K (+22.62 %) |
| Mar 20 2009 | AUXL | AUXILIUM PHARMACEU ... | MCKEE WILLIAM | Director | Option Exercise | A | 30.61 | 15,000 | 459,150 | 15,000 | |
| Mar 17 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | M | 4.78 | 4,933 | 23,580 | 95,067 | |
| Mar 17 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Sell | S | 29.79 | 4,933 | 146,958 | 21,281 | 26.2 K to 21.3 K (-18.82 %) |
| Mar 17 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Buy | M | 4.78 | 4,933 | 23,580 | 26,214 | 21.3 K to 26.2 K (+23.18 %) |
| Mar 17 2009 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Option Exercise | M | 7.81 | 30,000 | 234,300 | 470,000 | |
| Mar 17 2009 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Sell | S | 29.73 | 30,000 | 891,978 | 124,054 | 154.1 K to 124.1 K (-19.47 %) |
| Mar 17 2009 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Buy | M | 7.81 | 30,000 | 234,300 | 154,054 | 124.1 K to 154.1 K (+24.18 %) |
| Mar 03 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | A | 32.72 | 20,000 | 654,400 | 20,000 | |
| Mar 03 2009 | AUXL | AUXILIUM PHARMACEU ... | Mattila Jyrki | Executive Vice Pres ... | Option Exercise | A | 32.72 | 20,000 | 654,400 | 20,000 | |
| Mar 03 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Option Exercise | A | 32.72 | 20,000 | 654,400 | 20,000 | |
| Mar 03 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 32.72 | 20,000 | 654,400 | 20,000 | |
| Mar 03 2009 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Option Exercise | A | 32.72 | 40,000 | 1,308,800 | 40,000 | |
| Feb 27 2009 | AUXL | AUXILIUM PHARMACEU ... | DelConte Anthony | Chief Medical Offic ... | Option Exercise | A | 28.50 | 30,900 | 880,650 | 30,900 | |
| Feb 27 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Option Exercise | A | 28.50 | 30,900 | 880,650 | 30,900 | |
| Feb 27 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | A | 28.50 | 30,900 | 880,650 | 30,900 | |
| Feb 27 2009 | AUXL | AUXILIUM PHARMACEU ... | Mattila Jyrki | Executive Vice Pres ... | Option Exercise | A | 28.50 | 30,900 | 880,650 | 30,900 | |
| Feb 27 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Option Exercise | A | 28.50 | 30,900 | 880,650 | 30,900 | |
| Feb 27 2009 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Option Exercise | A | 28.50 | 75,000 | 2,137,500 | 75,000 | |
| Feb 19 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Sell | S | 31.55 | 3,450 | 108,837 | 21,281 | 24.7 K to 21.3 K (-13.95 %) |
| Feb 05 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Option Exercise | M | 13.39 | 1,850 | 24,772 | 82,600 | |
| Feb 05 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Sell | S | 32.26 | 1,850 | 59,684 | 14,835 | 16.7 K to 14.8 K (-11.09 %) |
| Feb 05 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Buy | M | 13.39 | 1,850 | 24,772 | 16,685 | 14.8 K to 16.7 K (+12.47 %) |
| Jan 21 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Payment of Exercise | F | 30.00 | 1,128 | 33,840 | 9,137 | 10.3 K to 9.1 K (-10.99 %) |
| Jan 21 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Grant | A | 0.00 | 3,750 | 0 | 10,265 | 6.5 K to 10.3 K (+57.56 %) |
| Jan 21 2009 | AUXL | AUXILIUM PHARMACEU ... | Mattila Jyrki | Executive Vice Pres ... | Payment of Exercise | F | 30.00 | 1,296 | 38,880 | 14,553 | 15.8 K to 14.6 K (-8.18 %) |
| Jan 21 2009 | AUXL | AUXILIUM PHARMACEU ... | Mattila Jyrki | Executive Vice Pres ... | Grant | A | 0.00 | 3,750 | 0 | 15,849 | 12.1 K to 15.8 K (+30.99 %) |
| Jan 21 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Payment of Exercise | F | 30.00 | 602 | 18,060 | 14,835 | 15.4 K to 14.8 K (-3.90 %) |
| Jan 21 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Grant | A | 0.00 | 2,000 | 0 | 15,437 | 13.4 K to 15.4 K (+14.88 %) |
| Jan 21 2009 | AUXL | AUXILIUM PHARMACEU ... | DelConte Anthony | Chief Medical Offic ... | Payment of Exercise | F | 30.00 | 726 | 21,780 | 1,274 | 2 K to 1.3 K (-36.30 %) |
| Jan 21 2009 | AUXL | AUXILIUM PHARMACEU ... | DelConte Anthony | Chief Medical Offic ... | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
| Jan 21 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Payment of Exercise | F | 30.00 | 1,299 | 38,970 | 24,731 | 26 K to 24.7 K (-4.99 %) |
| Jan 21 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Grant | A | 0.00 | 3,750 | 0 | 26,030 | 22.3 K to 26 K (+16.83 %) |
| Jan 16 2009 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Sell | S | 29.04 | 3,942 | 114,465 | 22,280 | 26.2 K to 22.3 K (-15.03 %) |
| Jan 21 2009 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Payment of Exercise | F | 30.00 | 1,946 | 58,380 | 124,054 | 126 K to 124.1 K (-1.54 %) |
| Jan 21 2009 | AUXL | AUXILIUM PHARMACEU ... | ANIDO ARMANDO | CEO & President | Grant | A | 0.00 | 6,000 | 0 | 126,000 | 120 K to 126 K (+5.00 %) |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Option Exercise | M | 13.39 | 5,550 | 74,315 | 84,450 | |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Sell | S | 30.00 | 660 | 19,800 | 13,437 | 14.1 K to 13.4 K (-4.68 %) |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Sell | S | 30.03 | 5,550 | 166,667 | 14,097 | 19.6 K to 14.1 K (-28.25 %) |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Graham Roger D Jr | Executive VP, Sales ... | Buy | M | 13.39 | 5,550 | 74,315 | 19,647 | 14.1 K to 19.6 K (+39.37 %) |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 13.16 | 637 | 8,383 | 39,363 | |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 9.15 | 1,500 | 13,725 | 43,500 | |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 5.36 | 3,833 | 20,545 | 101,167 | |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Sell | S | 30.04 | 5,970 | 179,338 | 6,515 | 12.5 K to 6.5 K (-47.82 %) |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 13.16 | 637 | 8,383 | 12,485 | 11.8 K to 12.5 K (+5.38 %) |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 9.15 | 1,500 | 13,725 | 11,848 | 10.3 K to 11.8 K (+14.50 %) |
| Jan 08 2009 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 5.36 | 3,833 | 20,545 | 10,348 | 6.5 K to 10.3 K (+58.83 %) |
| Jan 05 2009 | AUXL | AUXILIUM PHARMACEU ... | LANGER DENNIS | Director | Grant | A | 28.44 | 131 | 3,726 | 487 | 356 to 487 (+36.80 %) |
| Jan 05 2009 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Grant | A | 28.44 | 131 | 3,726 | 487 | 356 to 487 (+36.80 %) |
| Jan 05 2009 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 28.44 | 510 | 14,504 | 1,709 | 1.2 K to 1.7 K (+42.54 %) |
| Jan 05 2009 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 28.44 | 342 | 9,726 | 6,303 | 6 K to 6.3 K (+5.74 %) |
| Jan 05 2009 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Grant | A | 28.44 | 676 | 19,225 | 2,507 | 1.8 K to 2.5 K (+36.92 %) |
| Dec 22 2008 | AUXL | AUXILIUM PHARMACEU ... | Fickenscher James E | Chief Financial Off ... | Sell | S | 26.31 | 11,675 | 307,125 | 26,222 | 37.9 K to 26.2 K (-30.81 %) |
| Dec 22 2008 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Option Exercise | M | 5.36 | 5,000 | 26,800 | 105,000 | |
| Dec 22 2008 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Sell | S | 27.59 | 5,000 | 137,972 | 6,515 | 11.5 K to 6.5 K (-43.42 %) |
| Dec 22 2008 | AUXL | AUXILIUM PHARMACEU ... | Stacey Jennifer Evans | Executive VP & Gene ... | Buy | M | 5.36 | 5,000 | 26,800 | 11,515 | 6.5 K to 11.5 K (+76.75 %) |
| Oct 02 2008 | AUXL | AUXILIUM PHARMACEU ... | LANGER DENNIS | Director | Grant | A | 32.40 | 115 | 3,726 | 356 | 241 to 356 (+47.72 %) |
| Oct 02 2008 | AUXL | AUXILIUM PHARMACEU ... | FUCHS RENATO | Director | Grant | A | 32.40 | 115 | 3,726 | 356 | 241 to 356 (+47.72 %) |
| Oct 02 2008 | AUXL | AUXILIUM PHARMACEU ... | FETZER OLIVER | Director | Grant | A | 32.40 | 318 | 10,303 | 1,199 | 881 to 1.2 K (+36.10 %) |
| Oct 02 2008 | AUXL | AUXILIUM PHARMACEU ... | CLASSON ROLF A | Director | Grant | A | 32.40 | 324 | 10,498 | 5,961 | 5.6 K to 6 K (+5.75 %) |
| Oct 02 2008 | AUXL | AUXILIUM PHARMACEU ... | CHAMBON PHILIPPE | Director | Grant | A | 32.40 | 778 | 25,207 | 1,831 | 1.1 K to 1.8 K (+73.88 %) |
| Aug 14 2008 | AUXL | AUXILIUM PHARMACEU ... | Mattila Jyrki | Executive Vice Pres ... | Option Exercise | M | 13.16 | 8,750 | 115,150 | 26,250 | |
| Aug 14 2008 | AUXL | AUXILIUM PHARMACEU ... | Mattila Jyrki | Executive Vice Pres ... | Sell | S | 40.06 | 8,750 | 350,525 | 12,099 | 20.8 K to 12.1 K (-41.97 %) |